SteinHMasonDYGerdesJ. The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histocytic malignancies are derived from activated lymphoid cells. Blood1985; 66: 848–858.
2.
SteinHDDallenbachF. Diffuse large cell lymphomas of B and T cell type. In KnowlesDM ed. Neoplastic haematology. Baltimore: Williams & Wilkins. 1992: 675.
3.
RimokhRMagaudJPBergerF. A translocation involving a specific breakpoint (q, 35) on chromosome 5 is characteristic of anaplastic large cell lymphoma. Br J Haematol1989: 71: 31–36.
4.
MorrisSWKirsteinMNValentineMB. fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science1995; 267: 316–317.
5.
FioranaCVinciGSacchiS. Primary systemic anaplastic large-cell lymphoma (CD30+): Advances in biology and current therapeutic approaches (Review). Clinical Lymphoma2001; 2 (1): 29–37.
6.
SteinHFossHDurkopH. CD30+ anaplastic large cell lymphoma: a review of ots histopathologic, genetic, and clinicla features. Blood2000; 96 (12): 3681–3695.
7.
FalinaB. Anaplastic large cell lymphoma: pathological, molecular and clinical features (Review). Br J haematol2001; 114 (4): 741–760.
8.
JaffeES. Anaplastic large cell lymphoma: The shifting sands of diagnostic haematopathology. Modern Pathology2001; 14 (3): 219–228.
9.
ShiotaMNakamnraSIchinohasamaR. Anaplastic large cell lymphomas expressing chimeric protein p80 NPM/ALK: a distinct clinicopathologic entity. Blood1995; 86: 1954.
